Children with moderate to severe atopic dermatitis had improved skin barrier function with 16-week dupilumab treatment in both lesional and nonlesional skin, according to data published in Annals of ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

For tens of millions of Americans, allergy season ushers in a period of misery, characterized by runny noses, itchy eyes, ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Seasonal allergies are hitting harder and lasting longer than ever before. A new report from the Asthma and Allergy ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 23, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the ...

Despite affecting thousands of Ugandans, asthma remains widely misunderstood. Dr Kanishka Salunkhe, a pulmonologist, breaks down the common myths that delay diagnosis, fuel fear, and ...

Here are some tips from experts to keep allergy symptoms at bay — maybe even enough to allow you to enjoy the outdoors.

With gallows humour, Ian Rush is describing “the worst hat-trick” of his career. “I had Covid, a superflu and a severe asthma ...

Warmer temperatures will cause an early, strong season with high tree pollen levels moving north from the South and Ohio ...

Among patients with asthma who received four doses of depemokimab over 2 years, the annualized exacerbation rate was low, ...